HYDERABAD, India
Dr. Reddy’s Laboratories (NYSE: RDY) will announce results for the First Quarter ended June 30, 2013 on Tuesday, July 30, 2013 after the Board Meeting. The results will be available on the Company’s website www.drreddys.com.
|
Summary of Events |
||||||
| Event | Date and Time (IST) | Medium | ||||
| Release of financial results | July 30th, after the Board Meeting |
Email, Media, Company website, Business Wire |
||||
| Earnings Call | July 30th, 6.30 PM IST / 9:00 AM EDT |
Hosted by the Company |
||||
| Webcast of Earnings Call | July 30th, 6.30 PM IST / 9.00 AM EDT through August 4th, 2013 |
URL available on Company’s website, |
||||
| Transcripts of the Earnings call | Will be available on the Company’s website |
URL available on Company’s website, www.drreddys.com |
||||
Earnings Call
Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance.
| Conference Dial-In Numbers | |||
| Primary Number: | +91 22 6629 0356 | ||
| Secondary Number: | +91 22 3065 0136 | ||
|
The numbers listed above are universally accessible from all networks and all countries. |
|||
| Local Access Number: |
6000 1221 |
||
|
USA: 1 866 746 2133 |
|||
| International Toll Free Number: |
UK: 0 808 101 1573 |
||
|
Singapore: 800 101 2045 |
|||
|
Hong Kong: 800 964 448 |
|||
No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.
Audio Webcast
The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through August 4th, 2013. For play back dial in phone No: 022 3065 1212 and ID: 375#.
Transcript
The transcript of the earnings call will also be available on the Company’s website.
About Dr. Reddy’s
Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses – Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Major therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management and anti-infective. Major markets include India, USA, Russia-CIS and Europe apart from other select geographies within Emerging Markets.
For more information, log on to: www.drreddys.com
*EDT- Eastern Daylight Saving Time
CONTACT
Investor Relations:
Dr. Reddy’s Laboratories
Kedar
Upadhye, +91 40 66834297
kedaru@drreddys.com
or
Saunak
Savla, +91 40 49002135
saunaks@drreddys.com
or
Milan
Kalawadia (USA), +1 9082034931
mkalawadia@drreddys.com